Regional Analysis

Global Coronary Stents Market- Regional Analysis

Among region, North America is expected to dominate the market over the forecast period. This is attributed to the increasing adoption of organic growth strategies such as product launches by key players in the region to expand their product portfolio and it is expected to drive the market growth over the forecast period. For instance, in March 2022, Shockwave Medical, Inc., a pioneer in the development of Intravascular Lithotripsy (IVL), to treat severely calcified cardiovascular disease, announced the global commercial availability of the Shockwave M5+ peripheral IVL catheter after receiving both CE Mark and U.S. Food and Drug Administration (FDA) clearance.

The European region is expected to be the second largest region over the forecast period, owing to an increasing adoption of growth strategies such as product launches by key players in the region to expand product portfolio is expected to drive the market growth over the forecast period. For instance, in April 2022, Johnson & Johnson Private Limited’s subsidiary Cordis, a worldwide leader in cardiology and endovascular devices announced that it has received European market approval for its Cypher sirolimus-eluting stent for the treatment of newly-diagnosed coronary artery lesions.

North America: U.S. and Canada
Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
Middle East: GCC Countries, Israel, and Rest of Middle East
Africa: South Africa, North Africa, and Central Africa